Beth M. Jantzen is Chief Financial Officer of the company. Ms. Jantzen held the position of Controller since May 2013. Prior to joining the company, Ms. Jantzen was a senior manager at Marcum LLP, the Company’s independent registered accounting firm since June 23, 2014, where she managed multiple engagements and specialized in SEC policies, practices and procedures, including Sarbanes-Oxley compliance. Ms. Jantzen holds a Bachelor of Science (BS) in Accounting from the State University of New York at Binghamton and is also a Certified Public Accountant (CPA).
As the Chief Financial Officer of Applied Dna Sciences Inc, the total compensation of Beth Jantzen at Applied Dna Sciences Inc is $414,421. There are 4 executives at Applied Dna Sciences Inc getting paid more, with James Hayward having the highest compensation of $1,392,560.
Beth Jantzen is 39, she's been the Chief Financial Officer of Applied Dna Sciences Inc since 2015. There are 13 older and 1 younger executives at Applied Dna Sciences Inc. The oldest executive at Applied Dna Sciences Inc is Robert Catell, 80, who is the Director.
Beth's mailing address filed with the SEC is 50, Health Sciences Drive, Stony Brook University, Suffolk, New York, 11794, United States.
Over the last 21 years, insiders at Applied Dna Sciences Inc have traded over $13,655,198 worth of Applied Dna Sciences Inc stock and bought 12,115,698 units worth $17,246,871 . The most active insiders traders include Management Inc Rhl, Lawrence Lee e Dwyer Management Inc O. On average, Applied Dna Sciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $312,035. The most recent stock trade was executed by Scott L Anchin on 10 March 2021, trading 13,049 units of APDN stock currently worth $110,003.
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Applied Dna Sciences Inc executives and other stock owners filed with the SEC include: